BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23673813)

  • 21. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting c-Myc on cell growth and vascular endothelial growth factor expression in IN500 glioblastoma cells.
    Hu YH; Kong SQ; Kong HB; Wu JL; Chen Z
    Chin Med J (Engl); 2012 Jun; 125(11):2025-31. PubMed ID: 22884072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo.
    Li H; Chen L; Zhang A; Wang G; Han L; Yu K; Pu P; Kang C; Huang Q
    Int J Oncol; 2012 Jul; 41(1):169-78. PubMed ID: 22552702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
    Li GH; Wei H; Lv SQ; Ji H; Wang DL
    Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
    Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
    Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways.
    Hoshi H; Sawada T; Uchida M; Iijima H; Kimura K; Hirakawa K; Wanibuchi H
    Int J Oncol; 2013 Mar; 42(3):887-93. PubMed ID: 23292004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
    Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
    Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma.
    Kong BH; Shin HD; Kim SH; Mok HS; Shim JK; Lee JH; Shin HJ; Huh YM; Kim EH; Park EK; Chang JH; Kim DS; Hong YK; Kim SH; Lee SJ; Kang SG
    Int J Oncol; 2013 May; 42(5):1754-62. PubMed ID: 23483121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
    Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
    Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumstatin transfected into human glioma cell line U251 represses tumor growth by inhibiting angiogenesis.
    Ye HX; Yao Y; Jiang XJ; Yuan XR
    Chin Med J (Engl); 2013; 126(9):1720-5. PubMed ID: 23652057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of Nrf2 and HIF-1α in glioblastoma and their relationships to clinicopathologic features and survival.
    Ji X; Wang H; Zhu J; Tang Y; Zhou Y; Zhu L; Gao C; Li W; You W; Yu B; Xia Q
    Neurol Res; 2013 Dec; 35(10):1044-50. PubMed ID: 24070025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of Nrf2 and apoptotic signaling pathways in oroxylin A-mediated responses in HCT-116 colorectal adenocarcinoma cells and xenograft tumors.
    Hu R; Chen N; Yao J; Zhao Q; Zhang F; Li ZY; You QD; Guo QL
    Anticancer Drugs; 2012 Jul; 23(6):651-8. PubMed ID: 22526619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.
    Zhou Y; Jin G; Mi R; Zhang J; Zhang J; Xu H; Cheng S; Zhang Y; Song W; Liu F
    Oncotarget; 2017 May; 8(22):35877-35889. PubMed ID: 28415787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the NF-E2-related factor 2 pathway: a novel strategy for glioblastoma (review).
    Zhu J; Wang H; Fan Y; Lin Y; Zhang L; Ji X; Zhou M
    Oncol Rep; 2014 Aug; 32(2):443-50. PubMed ID: 24926991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferation of vascular smooth muscle cells in glioblastoma multiforme.
    Takeuchi H; Hashimoto N; Kitai R; Kubota T; Kikuta K
    J Neurosurg; 2010 Aug; 113(2):218-24. PubMed ID: 19929197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
    Escoll M; Lastra D; Pajares M; Robledinos-Antón N; Rojo AI; Fernández-Ginés R; Mendiola M; Martínez-Marín V; Esteban I; López-Larrubia P; Gargini R; Cuadrado A
    Redox Biol; 2020 Feb; 30():101425. PubMed ID: 31918259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
    Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
    Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.